Medprin Regenerative Total Risk Alpha
| 301033 Stock | | | 61.02 3.54 6.16% |
Historical market data for Medprin Regenerative Medical forms the basis of the Total Risk Alpha indicator shown here. The calculation draws on time-series market data across available periods. Medprin Regenerative has a market cap of 4.56 B, operating margin of 36.93%. Portfolio-level context is available through
Trending Equities. Tracking Medprin Regenerative Medical in a portfolio helps measure its contribution to overall performance. The information is presented without directional commentary. Broader economic conditions can influence Medprin Regenerative Medical's company valuation — related indicators include
signals in nation.
Medprin Regenerative Medical has current Total Risk Alpha of 0.2247. The total risk alpha measures the performance of an asset by comparing its returns with those of a selected benchmark portfolio.
Total Risk Alpha | = | RFR + (ER[b] - ER[a]) | x | STD[a] / STD[b] |
| = | 0.2247 | |
| ER[a] | = | Expected return on investing in Medprin Regenerative |
| ER[b] | = | Expected return on market index or selected benchmark |
| STD[a] | = | Standard Deviation of returns on Medprin Regenerative |
| STD[b] | = | Standard Deviation of selected market or benchmark |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
Total Risk Alpha Peers Comparison
Total Risk Alpha Relative To Other Indicators
Medprin Regenerative Medical is rated
fifth in total risk alpha among leading competitors. It is currently under evaluation in maximum drawdown among leading competitors reporting about
112.69 of Maximum Drawdown per Total Risk Alpha. At
112.69 , Medprin Regenerative Medical's Maximum Drawdown-to-Total Risk Alpha multiple reflects the spread between these metrics
The benchmark portfolio represents the market risk matched to the total risk of the stock ETF or fund.
Compare Medprin Regenerative to Peers
Other Technical Indicators